The WHO strategy for TB control and elimination

Marina Tadolini, Giovanni Battista Migliori

Source: Eur Respir Monogr 2012; 58: 242-253
Journal Issue: Tuberculosis
Disease area: Respiratory infections

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marina Tadolini, Giovanni Battista Migliori. The WHO strategy for TB control and elimination. Eur Respir Monogr 2012; 58: 242-253

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012


Clinical and operational value of the extensively drug-resistant tuberculosis definition
Source: Eur Respir J 2007; 30: 623-626
Year: 2007



Strategies against multidrug-resistant tuberculosis
Source: Eur Respir J 2002; 20: 66S-77S
Year: 2002



Epidemiology of TB
Source: Eur Respir Mon 2012; 58: 14-25
Year: 2012


Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009



Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007



Molecular surveillance of multi-drug resistant tuberculosis in Europe
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009



Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city
Source: Eur Respir J 2013; 41: 901-908
Year: 2013



Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003

Prevention of TB in areas of low incidence
Source: Eur Respir Mon 2012; 58: 72-83
Year: 2012


Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012



TB in migrants
Source: Eur Respir Mon 2012; 58: 194-205
Year: 2012


Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005



Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012


Our experience in multi drug resistant tuberculosis (MDR TB) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases
Source: Eur Respir J 2008; 31: 1155-1159
Year: 2008



Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011

Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis
Source: Eur Respir J 2009; 34: 180-183
Year: 2009